Myriad Genetics gets grant for prognosis of breast cancer treatment based on gene expression
According to GlobalData’s company profile on Myriad Genetics, Personalized medicine biomarkers was a key innovation area identified from patents. Myriad Genetics's grant share as of February 2024 was 31%. Grant share is based on the ratio of number of …